Davis's Drug Guide
Yosprala 81/40
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Yosprala 81/40." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110461/all/Yosprala_81_40.
Vallerand AHA, Sanoski CAC, Quiring CC. Yosprala 81/40. Davis's Drug Guide. F.A. Davis Company; 2023. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110461/all/Yosprala_81_40. Accessed September 8, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Yosprala 81/40. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110461/all/Yosprala_81_40
Vallerand AHA, Sanoski CAC, Quiring CC. Yosprala 81/40 [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2024 September 08]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110461/all/Yosprala_81_40.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Yosprala 81/40
ID - 110461
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110461/all/Yosprala_81_40
PB - F.A. Davis Company
ET - 18
DB - Medicine Central
DP - Unbound Medicine
ER -
